Functional Gastrointestinal Disorders in Children: A Survey on Clinical Approach in the Mediterranean Area

Elena Scarpato1, Paolo Quitadamo, Enriqueta Roman

  • 1*Department of Translational Medical Sciences, Section of Pediatrics, University Federico II, Naples, Italy†Department of Pediatrics, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain‡Department of Pediatrics, Institute for Child and Youth Health Care of Vojvodina, Medical Faculty Novi Sad, Novi Sad, Serbia§Referral Centre for Pediatric Gastroenterology and Nutrition, University Children's Hospital, Zagreb, Croatia||First Department of Pediatrics, University of Athens, Athens Children's Hospital "Agia Sophia", Athens, Greece¶Institute of Gastroenterology, Nutrition and Liver Diseases, Schneider Children's Medical Center of Israel, Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel#Clinical Centre of Montenegro, Institute for Children's Disease, Podgorica, Montenegro**Children's Hospital, University Medical Centre, Ljubljana, Slovenia††Makassed University General Hospital, Beirut, Lebanon‡‡Department of Internal Medicine and Medical Specialties, University Sapienza, Rome, Italy.

Insights

Pediatricians in the Mediterranean region rarely use Rome III criteria for diagnosing childhood functional gastrointestinal disorders (FGIDs). Management approaches for conditions like functional constipation and irritable bowel syndrome show significant variability among practitioners.

Area of Science:

  • Pediatric Gastroenterology
  • Clinical Practice Guidelines
  • Healthcare Management

Background:

  • Childhood functional gastrointestinal disorders (FGIDs) are prevalent, causing significant morbidity and high healthcare costs.
  • A multicenter study was conducted to evaluate the clinical approach to FGIDs in infants and children/adolescents within the Mediterranean Area.

Purpose of the Study:

  • To assess the diagnostic and therapeutic management of functional gastrointestinal disorders (FGIDs) in pediatric patients.
  • To evaluate the adherence to Rome III diagnostic criteria among pediatricians in the Mediterranean region.

Main Methods:

  • A survey was distributed to pediatricians across 9 Mediterranean countries.
  • The survey assessed the use of Rome II and III criteria and treatment strategies for irritable bowel syndrome (IBS), functional constipation (FC), and functional regurgitation (FR).

Main Results:

  • Rome III criteria were underutilized for diagnosing FC (28.8%), FR (22.3%), and IBS (25.9%).
  • Treatment for FC involved dietary modifications and osmotic laxatives; FR management relied on reassurance and thickened feedings, with some prescribing acid suppressants.
  • IBS therapy was symptom-based, with analgesics for pain, and dietary advice for diarrhea- or constipation-predominant types.

Conclusions:

  • The adoption of Rome III diagnostic criteria for FGIDs is not widespread among Mediterranean pediatricians.
  • Significant variability exists in the management of FGIDs across different countries in the surveyed Mediterranean region.
Abstract

Related Concept Videos

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
976
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
392
Gastrointestinal Motility Disorders01:20

Gastrointestinal Motility Disorders

Gastrointestinal or GI motility disorders are characterized by irregular gastrointestinal tract movements, disrupting food transit from the mouth to the anus. They are caused by damage or dysfunction in gut muscles or nerves. These disorders can cause symptoms such as severe constipation, diarrhea, abdominal pain, and swallowing difficulties. Disorders can affect any segment of the GI tract and range widely in severity, from common conditions like GERD to life-threatening conditions like...
1.4K
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation01:30

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
1.0K
Gastroesophageal Reflux Disease II: Clinical Features and Management01:29

Gastroesophageal Reflux Disease II: Clinical Features and Management

Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
1.0K
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
855